(Q34280930)

1 August 2017

1 reference

title

Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

Schirmbeck R

1

1 reference

PubMed ID

11405219

1 August 2017

Reimann J

series ordinal

2

1 reference

1 August 2017

1 April 2001

1 reference

1 August 2017

1 reference

1 August 2017

382

1 reference

1 August 2017

4

1 reference

1 August 2017

543-552

1 reference

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

1 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Polyvalent DNA vaccines with bidirectional promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Accessories for naked DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

DNA cancer vaccines: a gene gun approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

DNA-based immunization against the envelope proteins of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Properties of modified hepatitis B virus surface antigen particles carrying preS epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Processing of exogenous hepatitis B surface antigen particles for Ld-restricted epitope presentation depends on exogenous beta2-microglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

In vivo cytokine gene transfer by gene gun reduces tumor growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Immunization with plasmid DNA using a pneumatic gun.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

Epitope selection in major histocompatibility complex class I-mediated pathway is affected by the intracellular localization of an antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.068

21 January 2018

Identifiers

DOI

10.1515/BC.2001.068

1 reference

1 August 2017

1 reference

PubMed ID

11405219